Bragging and Blushing

It is our belief that validity of Peptides International’s products are affirmed by our own researchers’ numerous publications utilizing products made in their own laboratories.  We regularly feature them in the “PubCrawl” column in our weekly e-newsletter.  One such paper, coauthored by PI's President and CEO Dr. Michael W. Pennington, was published in the Journal of Pharmaceutical Sciences, and marked as the “Most Original and Most Significant Scientific Findings” in that issue!  The paper, titled, Pulmonary Delivery of the Kv1.3-Blocking Peptide HsTX1[R14A] for the Treatment of Autoimmune Diseases, and is just further confirmation that PI is truly “The Disulfide-Rich Peptide Experts!”   The titular peptide was synthesized in our labs.

Our motto for decades has been “Research today. Cures tomorrow.”  It is why we do what we do for our research - and yours!  

Industry News , Peptides International News

Robert Brousseau

See all articles from Robert Brousseau

Robert Brousseau, the Director of Marketing and Catalog Sales Development at Peptides International, has a wide range of responsibilities that include maintaining the Peptides International brand integrity and creating and implementing all materials related to marketing the company's product line. He is also tasked with the catalog portfolio sales.  Since joining the company in 2004, he has incorporated media that now includes printed material such as product brochures and the long-running PEPNET newsletter, along with the company Website, social media, email and other outlets.  Additionally, he assists the staff with IT issues they encounter.  Bob has a background in graphic design, marketing, and advertising, in addition to project management and packaging.  He received his B.A. in Art from the University of Louisville, with additional post-graduate studies in education and design.